Evidence map›Paper›PMID 39997746›Full record

ArticleMetabolites2025

Multifluid Metabolomics Identifies Novel Biomarkers for Irritable Bowel Syndrome.

Daniel Kirk, Panayiotis Louca, Ilias Attaye, Xinyuan Zhang, Kari E Wong, Gregory A Michelotti, Mario Falchi, Ana M Valdes, Frances M K Williams, Cristina Menni

Abstract read
In one paragraph

Article in Metabolites, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. The road to Rome IV and beyond: Evolution, refinements and future considerations for the Rome criteria for functional gastrointestinal disorders.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2025
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Daniel KirkDepartment of Twin Research & Genetic Epidemiology, King's College London, London SE1 7EH, UK.
Panayiotis LoucaDepartment of Twin Research & Genetic Epidemiology, King's College London, London SE1 7EH, UK.ORCID 0000-0001-5956-1433
Ilias AttayeDepartment of Twin Research & Genetic Epidemiology, King's College London, London SE1 7EH, UK.
Xinyuan ZhangDepartment of Twin Research & Genetic Epidemiology, King's College London, London SE1 7EH, UK.ORCID 0000-0001-9472-9641
Kari E WongMetabolon Inc., Research Triangle Park, Morrisville, NC 27560, USA.
Gregory A MichelottiMetabolon Inc., Research Triangle Park, Morrisville, NC 27560, USA.ORCID 0000-0002-3936-4675
Mario FalchiDepartment of Twin Research & Genetic Epidemiology, King's College London, London SE1 7EH, UK.
Ana M ValdesDepartment of Twin Research & Genetic Epidemiology, King's College London, London SE1 7EH, UK.ORCID 0000-0003-1141-4471
Frances M K WilliamsDepartment of Twin Research & Genetic Epidemiology, King's College London, London SE1 7EH, UK.
Cristina MenniDepartment of Twin Research & Genetic Epidemiology, King's College London, London SE1 7EH, UK.ORCID 0000-0001-9790-0571

Funding

Medical Research Council MR/W026813/1Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

irritable bowel syndromeserumstoolurine metabolomics

Identifiers

PMID39997746
PMCPMC11857683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.